Jun 2026 (Q2 FY26) — Aug 7, 2026
ACM Research Q2 FY26 — Strong Order Growth & Panel-Level Plating Orders
Read the full callACM Research (ACMR) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
ACM Research earnings: last reported Fri, 7 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 293 | +36.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 17.0 | +2.3 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 89.0 | +199.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Guidance
What management said, and what became of it
16 of 24 judged targets kept · 31 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Panel-level plating tool orders | volume production order for 550x510 and additional evaluation of 310x310 | Mar 2026 | Today, I'm pleased to announce that we have received order from advanced packaging customers for our panel level horizontal plating tool, addressing both 510 by 550-millimeter and 310 x 310-millimeter panel size while a production order from existing customers in Mainland China and the second one is the evaluation system for a new customer in Asia. | Achieved |
| Revenue contribution from furnace | accelerate in 2025 | Dec 2024 | Ghosted | |
| Effective Tax Rate | 8% to 10% | Dec 2025 | For 2026, we expect our effective tax range in the 10% to 12% range. | Revised Down |
8 of ACM Research, Inc.'s 55 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 52 more targets are in the full ledger.
Claimed
- Orders increased 105% year-over-year for the first half of 2026.
- Q2 revenue was $293 million, up 36% year-over-year.
- ECP, furnace, and other technology revenue grew 168% year-over-year, representing 44% of revenue.
- Advanced packaging revenue (excluding ECP, services, spares) was up 153% year-over-year.
- Received production orders for panel-level horizontal plating tools from advanced packaging customers.
Qualified
- Single wafer, cleaning, and semi-critical cleaning tool revenue was down 14% year-over-year.
- Gross margin decreased to 46.0% from 48.7% year-over-year.
- Cash used by operations was $6.4 million in Q2 FY26.
- Component shortages and supply chain tightness are noted as potential impacts on shipment timing.
Price
$56.09 +5.63% · +$2.99
Performance +47.3% 1Y
1Y: $38.07 on 17 Oct 2025 → $56.09. High $126.89 (30 Jun 2026), low $29.67 (20 Nov 2025).
- Previous close
- $53.1
- 52-week range
- $29.67 – $126.89
- One year
- +40.97%
Overview
- Symbol
- ACMR
- Sector
- Information Technology
- Exchange
- US
- Currency
- USD
Guidance
What management said, and what became of it
16 of 24 judged targets kept · 31 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Panel-level plating tool orders | volume production order for 550x510 and additional evaluation of 310x310 | Mar 2026 | Today, I'm pleased to announce that we have received order from advanced packaging customers for our panel level horizontal plating tool, addressing both 510 by 550-millimeter and 310 x 310-millimeter panel size while a production order from existing customers in Mainland China and the second one is the evaluation system for a new customer in Asia. | Achieved |
| Revenue contribution from furnace | accelerate in 2025 | Dec 2024 | Ghosted | |
| Effective Tax Rate | 8% to 10% | Dec 2025 | For 2026, we expect our effective tax range in the 10% to 12% range. | Revised Down |
Claimed
- Orders increased 105% year-over-year for the first half of 2026.
- Q2 revenue was $293 million, up 36% year-over-year.
- ECP, furnace, and other technology revenue grew 168% year-over-year, representing 44% of revenue.
- Advanced packaging revenue (excluding ECP, services, spares) was up 153% year-over-year.
- Received production orders for panel-level horizontal plating tools from advanced packaging customers.
Qualified
- Single wafer, cleaning, and semi-critical cleaning tool revenue was down 14% year-over-year.
- Gross margin decreased to 46.0% from 48.7% year-over-year.
- Cash used by operations was $6.4 million in Q2 FY26.
- Component shortages and supply chain tightness are noted as potential impacts on shipment timing.
The full ledger
Open ACM Research, Inc.’s full ledger
A free account opens 5 company ledgers a month. All 55 tracked commitments, with each call’s wording and source.
Call summaries
Mar 2026 (Q1 FY26) — May 7, 2026
ACM Research Q1 FY26 — Strong Revenue Growth Driven by ECP and Advanced Packaging
Read the full callDec 2025 (Q4 FY25) — Feb 26, 2026
ACM Research Q4 FY25 — Strong Product Cycle and Global Expansion Drive Growth
Read the full callEvery analysed call
ACM Research earnings calls (ACMR)
Financials
What the filings say
Net profit, year on year: +199% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 204 | 223 | 172 | 215 | 269 | 244 | 231 | 293 |
| Operating profit | 44 | 44 | 26 | 32 | 29 | 23 | 36 | 50 |
| Operating margin | 21.7% | 19.7% | 15.0% | 14.7% | 10.8% | 9.4% | 15.6% | 17.0% |
| Interest | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 43 | 56 | 27 | 38 | 49 | 21 | 30 | 136 |
| Tax rate | 9.4% | 30.7% | 7.9% | 5.0% | 5.5% | 31.6% | 12.6% | 9.9% |
| Net profit | 31 | 31 | 20 | 30 | 36 | 8 | 17 | 89 |
| EPS ($ per share) | 0.49 | — | 0.32 | 0.47 | 0.56 | — | 0.26 | 1.31 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Reserves | -3 | 16 | 34 | 64 | 94 | 157 | 260 | 350 |
| Total liabilities | 51 | 60 | 133 | 241 | 423 | 565 | 760 | 942 |
| Fixed assets | 4 | 4 | 8 | 14 | 83 | 202 | 269 | 315 |
| Investments | — | 0 | 28 | 29 | 20 | 21 | 19 | 36 |
| Total assets | 103 | 218 | 341 | 1,052 | 1,236 | 1,491 | 1,856 | 2,872 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 7 | 9 | -14 | -40 | -62 | -75 | 152 | -10 |
| Cash from investing | -2 | -6 | -70 | -11 | -266 | -7 | -12 | -390 |
| Cash from financing | 5 | 87 | 33 | 539 | 46 | 19 | 92 | 742 |
| Net cash flow | 9 | 91 | -46 | 491 | -315 | -65 | 228 | 355 |
| Capital expenditure | -2 | -1 | -5 | -9 | -91 | -62 | -82 | -56 |
| Free cash flow | 5 | 8 | -19 | -49 | -153 | -137 | 70 | -67 |
ACMR operating KPIs by quarter
| KPI | Dec 2025 Q4 FY25 | Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|---|
| Shipments | $228MTotal shipments were $228 million for the fourth quarter, down 13.5% and $854 million for the full year of 2025, down 12.2%.Source: earnings call transcript | $240.7MTotal shipments were $240.7 million, up 53.6%.Source: earnings call transcript | $281.5MTotal shipments were $281.5 million, up 36.4%.Source: earnings call transcript | +17% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Insider filings
102 filings between Nov 12, 2025 and Sep 9, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$51.15M
72 sales by 8 insiders
100% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 29
- Option exercise — converted options into shares
Also filed: 1 gift.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Wang David H | — | $28.98M | Sep 9, 2026 |
| McKechnie Mark | — | $9.85M | Aug 20, 2026 |
| Chen Fuping | — | $3.98M | Dec 3, 2025 |
| Liu Tracy | — | $2.85M | Mar 11, 2026 |
| Feng Lisa | — | $2.44M | Mar 6, 2026 |
| Cheav Sotheara | — | $1.59M | Jun 5, 2026 |
| Dun Haiping | — | $954.1K | Aug 18, 2026 |
| Pappis Charles C | — | $510.4K | Apr 17, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 1,100 | $85.3K |
| Sep 9, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 11,666 | $881.7K |
| Sep 9, 2026 | Wang David H See Remarks | Option exercise 10b5-1 plan | 70,000 | $70.0K |
| Sep 9, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 33,493 | $2.47M |
| Sep 9, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 4,807 | $368.8K |
| Sep 9, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 18,934 | $1.41M |
| Sep 8, 2026 | Wang David H See Remarks | Option exercise 10b5-1 plan | 70,000 | $70.0K |
| Sep 8, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 1,500 | $117.9K |
| Sep 8, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 12,323 | $962.2K |
| Sep 8, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 51,374 | $3.96M |
| Sep 8, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 4,803 | $365.0K |
| Aug 20, 2026 | McKechnie Mark See Remarks | Option exercise 10b5-1 plan | 30,199 | $588.6K |
| Aug 20, 2026 | McKechnie Mark See Remarks | Sale 10b5-1 plan | 13,625 | $1.04M |
| Aug 20, 2026 | McKechnie Mark See Remarks | Sale 10b5-1 plan | 11,209 | $873.1K |
| Aug 20, 2026 | McKechnie Mark See Remarks | Option exercise 10b5-1 plan | 25,000 | $347.3K |
| Aug 20, 2026 | McKechnie Mark See Remarks | Sale 10b5-1 plan | 30,365 | $2.35M |
| Aug 18, 2026 | Dun Haiping Director | Sale 10b5-1 plan | 1,200 | $96.3K |
| Aug 18, 2026 | Dun Haiping Director | Sale 10b5-1 plan | 3,400 | $276.5K |
| Aug 18, 2026 | Dun Haiping Director | Option exercise 10b5-1 plan | 5,000 | $28.0K |
| Aug 18, 2026 | Dun Haiping Director | Sale 10b5-1 plan | 400 | $32.9K |
| Jun 5, 2026 | Cheav Sotheara See remarks | Sale 10b5-1 plan | 400 | $33.6K |
| Jun 5, 2026 | Cheav Sotheara See remarks | Sale 10b5-1 plan | 968 | $80.0K |
| Jun 5, 2026 | Cheav Sotheara See remarks | Sale 10b5-1 plan | 2,384 | $194.8K |
| Jun 5, 2026 | Cheav Sotheara See remarks | Option exercise 10b5-1 plan | 5,399 | $75.0K |
| Jun 5, 2026 | Cheav Sotheara See remarks | Sale 10b5-1 plan | 1,647 | $140.7K |
| Jun 4, 2026 | Cheav Sotheara See remarks | Sale 10b5-1 plan | 2,839 | $243.5K |
| Jun 4, 2026 | Cheav Sotheara See remarks | Sale 10b5-1 plan | 9,212 | $784.0K |
| Jun 4, 2026 | Cheav Sotheara See remarks | Sale 10b5-1 plan | 1,300 | $109.3K |
| Jun 4, 2026 | Cheav Sotheara See remarks | Option exercise 10b5-1 plan | 13,351 | $185.4K |
| Jun 4, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 826 | $72.6K |
| Jun 4, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 8,581 | $747.7K |
| Jun 4, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 10,992 | $946.1K |
| Jun 4, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 17,543 | $1.49M |
| Jun 4, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 2,060 | $172.8K |
| Jun 4, 2026 | Wang David H See Remarks | Option exercise 10b5-1 plan | 40,002 | $40.0K |
| Jun 3, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 5,843 | $539.8K |
| Jun 3, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 9,925 | $901.0K |
| Jun 3, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 6,295 | $560.1K |
| Jun 3, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 32,450 | $2.92M |
| Jun 3, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 4,300 | $376.6K |
| Jun 3, 2026 | Wang David H See Remarks | Option exercise 10b5-1 plan | 60,000 | $60.0K |
| Jun 3, 2026 | Wang David H See Remarks | Sale 10b5-1 plan | 1,187 | $110.4K |
| May 19, 2026 | Dun Haiping Director | Sale 10b5-1 plan | 500 | $32.5K |
| May 19, 2026 | Dun Haiping Director | Sale 10b5-1 plan | 1,333 | $85.1K |
| May 19, 2026 | Dun Haiping Director | Sale 10b5-1 plan | 1,858 | $125.5K |
| May 19, 2026 | Dun Haiping Director | Option exercise 10b5-1 plan | 5,000 | $28.0K |
| May 19, 2026 | Dun Haiping Director | Sale 10b5-1 plan | 1,309 | $88.0K |
| Apr 17, 2026 | Pappis Charles C Director | Option exercise 10b5-1 plan | 5,000 | $145.9K |
| Apr 17, 2026 | Pappis Charles C Director | Sale 10b5-1 plan | 5,000 | $260.0K |
| Mar 12, 2026 | McKechnie Mark See Remarks | Option exercise 10b5-1 plan | 38,551 | $751.4K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for ACM Research, Inc.
Free account. Everything above stays public.
Write why you follow ACM Research, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading